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Surgery for Pulmonary Sclerosing Hemangioma: 
Lobectomy versus Limited Resection
Joon  Seok  Park,  M.D.*,  Kwhanmien  Kim,  M.D.*,  Sumin  Shin,  M.D.*, 
Hunbo  Shim,  M.D.*,  Hong  Kwan  Kim,  M.D.*
Background:  Pulmonary sclerosing hemangioma is a rare thoracic tumor, and pathophysiology or clinical course of 
this tumor is not yet fully described. Furthermore, there is no consensus on the standard operative procedure for 
this tumor. Material and Methods: Medical records of thirty-two patients, who underwent surgical resection of pul-
monary sclerosing hemangioma from 1996 to 2007, were retrospectively reviewed. Results: Nineteen patients under-
went lobectomy and thirteen patients underwent limited resection. Video-assisted thoracoscopic surgery was per-
formed in 9 patients in the latter group. Lymph node dissection was done in 21 patients, and one patient was 
found to have lymph node metastasis of the tumor. There was no postoperative complication, no early death and 
no tumor-related late mortality. The mean follow-up duration was 39.3 months (2 months∼129 months), and all 
patients were free of local recurrence and distant metastasis during this period. There was no significant difference 
in patient’s characteristics between the two groups, except that the mean hospital stay was shorter in limited re-
section group than in lobectomy group (p=0.0031). Conclusion: Pulmonary sclerosing hemangioma usually requires 
surgical resection for both diagnosis and treatment. Limited resection can decrease hospital stay with a surgical 
outcome comparable to lobectomy, and may be preferred to lobectomy if sufficient resection margin can be 
achieved.
Key words: 1. Lung neoplasms 
2. Surgery 
3. Hemangioma
INTRODUCTION
Pulmonary  sclerosing  hemangioma  (PSH)  is  a  rare  benign 
tumor  which  was  first  described  by  Liebow  and  Hubbell  [1]. 
PSH  usually  presents  as  an  asymptomatic  solitary  peripheral 
nodule, predominantly in women. PSH is generally considered 
as  benign  tumor,  but  some  reports  suggested  the  malignant 
potential  of  this  tumor.  The  optimal  surgical  strategy  for 
treating  PSH  has  not  been  established.  The  purpose  of  this 
study  is  to  compare  the  outcome  of  limited  resection  with 
that  of  lobectomy  to  determine  the  optimal  surgical  strategy 
of  this  tumor.
MATERIAL AND METHODS
Between January 1995 and December 2007, 32 patients un-
derwent  surgical  resection  of  PSH  at  out  institution.  Their 
medical records were retrospectively reviewed to compare the Joon Seok Park, et al
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Table 1. Operative technique and approach
Techinique No.  of  patients
Lobectomy
Limited  resection
Wedge  resection
Segmentectomy
Others
19  (59%)
13  (41%)
5
1
7
Approach
Thoracotomy
Lobectomy
Limited  resection
VATS*
Lobectomy
Limited  resection
18  (56%)
14
 4
14  (44%)
 5
 9
*VATS=Video-assisted  thoracoscopic  surgery.
clinical  characteristics  and  postoperative  outcomes  of  the  two 
groups with different surgical procedures: lobectomy and lim-
ited  resection,  which  was  defined  as  lung  resection  with  an 
extent  smaller  than  that  of  lobectomy.  There  were  no  clear 
criteria for the selection of the surgical procedure, but limited 
resection  tended  to  be  preferred for peripheral small-sized  tu-
mor,  and  in  the  recent  series  after  the  introduction  of  vid-
eo-assisted  thoracoscopic  surgery  (VATS). 
Thirty-one patients were female, and the mean age at oper-
ation  was  47.8  years,  ranging  from  23  to  73  years.  Twelve 
patients  had  non-specific  subjective  symptoms  before  being 
diagnosed  as  having  PSH,  such  as  cough,  chest  discomfort, 
and mild dyspnea. Five patients had a history of blood-tinged 
sputum. 
All  patients  were  initially  diagnosed  with  solitary  pulmo-
nary nodule (SPN) on simple chest X-ray, which prompted us 
to  conduct  computed  tomography  (CT)  scan.  PSH  was  sus-
pected  in  10  patients,  as  one  of  the  differential  diagnoses  in 
nine  cases,  and  as  a  single  compatible  diagnosis  in  one  case. 
Enhanced  spiral  CT  scan  in  our  hospital  improved  diagnostic 
accuracy  by  indicating  PSH  in  seven  out  of  eight  patients.
Determination  of  preoperative  pathologic  diagnosis  was  at-
tempted  in  12  patients  with  fine  needle  aspiration  (FNA). 
Three  patients  were  misdiagnosed  preoperatively  as  ad-
enocarcinoma of the lung, and three were diagnosed with oth-
er benign lung tumors such as hemangioma or hamartoma. In 
two  patients,  PSH  was  one  of  the  two  differential  diagnoses 
(i.e. PSH and adenocarcinoma). The correct preoperative diag-
nosis  of  PSH  was  made  only  in  4  cases. 
Additionally,  intra-operative  frozen  biopsy  failed  to  diag-
nose  PSH  in  one  case,  who  was  reported  to  have  bronchio-
loalveolar  carcinoma  (BAC). 
The  study  population  was  divided  into  two  groups  accord-
ing  to  the  extent  of  resection.  Lobectomy  group  included  19 
patients,  and  limited  resection  group  included  13  patients, 
which consisted of 1 segmentectomy, 5 wedge resections and 
7 other  minor  resections  of tumor such as  precision excision. 
Conventional  open  thoracotomy  was  done  in  19  patients  and 
VATS in 13 patients. Thoracoscopic surgery was preferred in 
limited  resection  group  (9/13,  69%).  The  operative  technique 
and  approach  was  summarized  in  Table  1. 
All patients were followed up postoperatively. CT scan was 
done between postoperative 3
rd and 6
th months in most of the 
patients.  After  initial  postoperative  CT  examination  CT  scan 
was  performed  annually  for  more  than  3  years. 
Descriptive  statistics  were  used  to  describe  patient  charac-
teristics  and  outcomes.  The  normally  distributed  continuous 
data  were  expressed  as  means  with  standard  deviations. 
Categorical  data  were  expressed  as  absolute  values  with 
percentages.  Student  t t e s t s  a n d  C h i  s q u a r e  o r  F i s h e r  e x a c t  
tests  were  used  to  compare  the  continuous  and  categorical 
variables,  respectively.  A  p-value  of  less  than  0.05  was  con-
sidered  significant. 
RESULTS 
The clinical characteristics and pathologic data of the study 
population are described in Table 2. Among 32 patients, thir-
teen  patients  underwent  a  limited  resection.  The  lobectomy 
group  consisted  of  1  male  and  18  female.  The  limited  re-
section  group  consisted  of  only  female  patients. 
Two  patients  had  multiple  nodules.  One  patient  with  two 
nodules  in  the  right  middle  lobe  (RML)  received  precision 
excision of the nodules, and the other patients with two nod-
ules  in  the  right  lower  lobe  received  right  lower  lobectomy. 
The  rest  of  the  patients  had  a  single  nodule.  In  two  patients, 
the  masses  were  found  in  unusual  locations.  One  tumor  was 
located in the major fissure, and the other one was located in 
the  mediastinum  as  a  visceral  pleural-based  pedunculated Surgery for Pulmonary Sclerosing Hemangioma: Lobectomy versus Limited Resection
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Table 2. Clinical characteristics and pathologic data of the patients
All  patients Lobectomy Limited  resection p-value
Patients,  No.
Age,  years  (mean±SD*)
Gender,  No.
  M a l e
  F e m a l e
No.  of  nodule
  1
  2
Tumor  size,  cm  (mean±SD)
Location,  No.
    Right  upper  lobe
    Right  middle  lobe
    Right  lower  lobe
  L e f t  u p p e r  l o b e
  L e f t  l o w e r  l o b e
  O t h e r
†
LN
‡  dissection
    Performed
    Phositive  for  tumor,  No.
Hospital  stay,  days  (mean±SD*)
32
47.75
 1
31
30
 2
2.6
 3
 4
 5
 6
12
 2
21
 1
5.26
19
46.4±11.87
 1
18
18
 1
2.2±1.33
 2
 1
 3
 5
 8
 0
19
 1
6.5±2.18
13
49.7±10.67
 0
13
12
 1
0.9±1.99
 1
 3
 2
 1
 4
 2
 2
 0
4.1±1.89
0.4317
0.4007
0.7804
0.2701
0.2936
0.0031
*SD=Standard  deviation; 
†Other=Pleura  (1),  mediastinum  (1); 
‡LN=Lymph  node.
mass.  The mean  diameter of  the tumors was 2.6  cm, varying 
from 1 cm to 8 cm, and the tumor size was larger than 4 cm 
in  diameter  only  in  four  patients. 
Lymph node biopsy or dissection was done in 21, and one 
patient  was  found  to  have  lymph  node  metastasis  at  the  left 
upper  pulmonary  vein  lymph  node.  In  that  case,  the  patient 
underwent completion lobectomy because of the possible ma-
lignant  characteristics  of  PSH  with  lymph  node  metastasis. 
However,  there  was  no  clinical  evidence  of  local  recurrence 
o r  d i s t a n t  m e t a s t a s i s  d u r i n g  t h e  1 0 - y e a r  f o l l o w - u p  i n  t h i s  
patient. 
For  tumors  embedded  in  pulmonary  parenchyma,  at  least 
0.5 cm of resection margin was achieved. The tumors located 
in  the  interlobar  fissure  and  visceral  pleura  were  solid  and 
well-encapsulated  mass  without  invading  adjacent  tissue.
There  was  no  postoperative  complication,  and  no  early  or 
late  tumor-related  mortality.  The  mean  follow-up  period  was 
39.3  months  (from  2  to  129  months),  and  all  patients  were 
free  of  local  recurrence  or  distant  metastasis  during  the  fol-
low-up  period.
There  was  no  significant  difference  in  basic  patient’s  char-
acteristics  and  surgical  resul t s  b e t w e e n  t h e  t w o  g r o u p s .
The  mean  hospital  stay  was  significantly  shorter  in  limited 
resection  group  (4.01  days)  than  in  lobectomy  group  (6.5 
days)  (p=0.0031).
DISCUSSION
Pulmonary  sclerosing  hemangioma,  first  described  by 
Liebow and Hubbell in 1956 [1], is a rare primary pulmonary 
tumor.  It  predominantly  involves  women  and  is  more  com-
mon  among  Asians. 
Although the biologic behavior of PSH is not clear and its 
histogenesis is still under debates, it has recently been claim-
ed  that  PSH  originates  from  primitive  respiratory  epithelial 
cells  [2,3]. 
The  clinical  behavi o r  o f  P S H  h a s  n o t  b e e n  c l e a r l y  
elucidated. PSH presents mostly as a single solid mass in the 
lung,  with  right-side  predominance,  but  it  occasionally  ex-
hibits as multiple nodules [2] with an incidence of 4∼5%. It 
can  also  be  found  elsewhere  (i.e.  mediastinum  or  pleura)  in 
the  thorax  [4].  We  also  experienced  two  cases  of  multiple Joon Seok Park, et al
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nodules  and  two  cases  of  unusual  locations. 
PSH  is  considered  to  have  benign  nature.  However,  there 
have  been  several  reports  on  the  malignant  potential  of  the 
tumor.  Ever  since  Tanaka  and  colleagues  reported  the  first 
case of PSH with lymph node metastasis [5], there have been 
sporadic reports on its metastatic nature [6-10]. There was al-
so  a  case  report  on  the  local  recurrence  of  PSH  [11].  The 
prognosis  of  PSH  does  not  appear  to  be  affected  by  these 
malignant  potentials,  for  there  has  been  no  documented  mor-
tality  caused  by  PSH.  Among  the  32  patients  in  our  study, 
one patient with a mass located at the interlobar major fissure 
was  found  to  have  regional  lymph  node  metastasis.  This  pa-
tient  had  been  initially  diagnosed  as  having  fibrous  tumor  of 
the  pleura  preoperatively.  Postoperative  permanent  pathology 
revealed  findings  compatible  with  PSH,  and  the  patient  re-
ceived  reoperation  for  completion  lobectomy.  The  lymph 
node metastasis was found at the pulmonary vein lymph node 
in  the  lobectomy  specimen.  After  10-year  follow-up,  there 
was evidence of tumor recurrence in the adjacent lung paren-
chyma  or  lymph  nodes. 
Even  though  many  authors  in  the  literatures  pertaining  to 
the  surgical  strategy  for  PSH  preferred  limited  resection  (i.e. 
wedge  resection  or  enucleation)  to  anatomical  resection  (i.e. 
lobectomy),  there  has  still  been  no  consensus  on  the  optimal 
extent of resection for PSH. One of the important reasons for 
this  is the  inaccuracy  of  preoperative diagnosis  for  PSH.  The 
cytological  findings  of  PSH  have  been  rarely  described,  and 
bear  a  strong  resemblance  to  certain  types  of  pulmonary 
malignancies.  Differential  diagnoses  of  PSH  based  on  cytol-
ogy include pulmonary adenocarcinoma, BAC, and pulmonary 
carcinoid [12]. Radiologically, PSH usually presents as a soli-
tary,  well-circumscribed  mass  without  cavitation.  The  tumor 
typically  shows  heterogeneous  areas  of  attenuation,  marked 
enhancement,  and  air  trapping,  which  is  forms  “air  meniscus 
sign”  on  plain  chest  films.  However,  these  findings  can  also 
be  seen  in  tuberculoma,  aspergilloma,  hamartoma,  and  lung 
carcinoma.  A  Chinese  group,  which  favored  limited  resection 
in their report of 24 patients with PSH [13], also pointed out 
the  difficulties  in  the  precise  preoperative  diagnosis  of  PSH. 
In  this  study,  the  radiologic  prediction  diagnosis  of  PSH  was 
only made in 10 out of 32 cases. Preoperative cytological ex-
amination with fine needle aspiration was also misleading be-
cause eight out of twelve successful diagnostic procedures re-
sulted  in  misdiagnoses  of  pulmonary  adenocarcinoma  (5  cas-
es) or other lung tumors (3 cases). In one case, even the fro-
zen  section  in  the  operating  room  failed  to  identify  PSH, 
which was misdiagnosed as BAC. As our experience accumu-
lates, pathologists in our institution reported 16 cases of PSH 
with  5  unusual  presentations  [14],  and  from  then  on,  the  ac-
curacy  of  preoperative  diagnosis  of  PSH  has  considerably 
improved.  Since  2007,  PSH  was  correctly  diagnosed  in  al-
most  all  cases  (7  cases  out  of  8  by  chest  CT  scan  and  all  3 
cases  by  fine  needle  cytology).  Regardless  of  the  extent  of 
surgery, all the patients in our current report are all alive and 
well  at  present  without  the  evidence  of  local  recurrence  or 
metastasis.   
CONCLUSION
Pulmonary  sclerosing hemangioma  usually  requires surgical 
resection  for  both  accurate  diagnosis  and  adequate  treatment. 
Limited  resection  can  decrease  hospital  stay  and  costs  with  a 
surgical  outcome  comparable  to  lobectomy.  Recent  progress 
in  preoperative  radiologic  and  pathologic  diagnosis  may  re-
duce  the  probability  of  unnecessary  lobectomy.
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